Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29156| Title: | Use of other disease-modifying therapies after or between alemtuzumab treatments: pooled results from the CAMMS223, and CARE-MS I and II studies over 8 years | Authors: | Vermersch, P. Baker, M. Bass, A. D. Berkovich, R. Comi, G. Eichau, S. Graves, D. Hunter, S. F. Ionete, C. Limmroth, V. Meuth, S. G. Naismith, R. T. Sharrack, B. Subei, A. Daizadeh, N. Choudhry, Z. VAN WIJMEERSCH, Bart |
Issue Date: | 2019 | Publisher: | WILEY | Source: | EUROPEAN JOURNAL OF NEUROLOGY, 26(SI), p. 866-867 | Notes: | [Vermersch, P.] Univ Lille, Lille, France. [Baker, M.] Collier Neurol Specialists, Naples, FL USA. [Bass, A. D.] Neurol Ctr San Antonio, San Antonio, TX USA. [Berkovich, R.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Eichau, S.] Hosp Univ Virgen Macarena, Seville, Spain. [Graves, D.] Atrium Hlth, Neurosci Inst Neurol, Charlotte, NC USA. [Hunter, S. F.] Adv Neurosci Inst, Franklin, TN USA. [Ionete, C.] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA. [Limmroth, V.] Klin Neurol & Palliat Med, Cologne, Germany. [Meuth, S. G.] Univ Munster, Munster, Germany. [Naismith, R. T.] Washington Univ, Sch Med, St Louis, MO USA. [Sharrack, B.] Univ Sheffield, Sheffield, S Yorkshire, England. [Sharrack, B.] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England. [Subei, A.] Mem Healthcare Syst, Hollywood, FL USA. [Daizadeh, N.; Choudhry, Z.] Sanofi, Cambridge, MA USA. [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. | Document URI: | http://hdl.handle.net/1942/29156 | ISSN: | 1351-5101 | e-ISSN: | 1468-1331 | ISI #: | 000474481004026 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.